Genedata Screener for HCS Advances Phenotypic Screening

Single-platform solution fulfills promise of phenotypic screening with full access to and integration with images, raw data, and data warehouses from different vendors(PRWeb January 08, 2013)Read the full story at http://www.prweb.com/releases/Gened…



Direct Marketing Partners Wins Sales Lead Management’s “Most…

Debra da Costa, President and CEO of Direct Marketing Partners (DMP), a leading provider of B2B lead generation services, and Tom Judge, DMP’s VP of Strategy and BusinessDevelopment, have again been…

(PRWeb January 08, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10295262.htm



Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical…

The U.S. Food and Drug Administration (FDA) approved JUXTAPID™ (lomitapide), a new, first-in-class treatment option for clinical management of patients with homozygous familial hypercholesterolemia…

(PRWeb January 08, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10293283.htm



ILVO-T&V Belgium Validates Charm Sciences ROSA Beta-Lactam and…

Prestigious laboratory validates Charm Sciences’ MRLBLRFTET2 test for detection of beta-lactam and tetracycline at levels for import to Russia, Kazakhstan, and Belarus.

(PRWeb January 08, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10288606.htm



ILVO-T&V Belgium Validates Charm Sciences ROSA Beta-Lactam and…

Prestigious laboratory validates Charm Sciences’ MRLBLRFTET2 test for detection of beta-lactam and tetracycline at levels for import to Russia, Kazakhstan, and Belarus.

(PRWeb January 08, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10288606.htm



Verified Clinical Trials Will Exhibit at the Annual 2013 SCOPE Summit…

Verified Clinical Trials is proud to announce their presence at the SCOPE Summit in Miami, Florida to discuss the largest North American clinical research volunteer database that stops dual enrollment…(PRWeb January 08, 2013)Read the full story at…